Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Science 37, Inc. Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials September 16, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC August 06, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Enrolls 42% of Trial Cohort in 8 Weeks July 18, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials June 27, 2024 From Science 37, Inc. Via GlobeNewswire CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial June 12, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial June 12, 2024 From Science 37, Inc. Via GlobeNewswire Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance May 13, 2024 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation” May 09, 2024 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial May 02, 2024 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment April 17, 2024 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment January 29, 2024 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Receives Top Honors in Everest PEAK Matrix® December 12, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) December 07, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023 December 05, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) November 10, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Third Quarter 2023 Financial Results November 07, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 06, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List September 20, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023 September 13, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan September 12, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards August 15, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) August 11, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Second Quarter 2023 Financial Results August 08, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023 July 25, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU) July 11, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 07, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 09, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform" May 18, 2023 From Science 37, Inc. Via GlobeNewswire Tickers SNCE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.